Influence of ApoA-I Structure on the ABCA1-mediated Efflux of Cellular Lipids
Overview
Authors
Affiliations
The influence of apolipoprotein (apo) A-I structure on ABCA1-mediated efflux of cellular unesterified (free) cholesterol (FC) and phospholipid (PL) is not well understood. To address this issue, we used a series of apoA-I mutants to examine the contributions of various domains in the molecule to ABCA1-mediated FC and PL efflux from mouse J774 macrophages and human skin fibroblasts. Irrespective of the cell type, deletion or disruption of the C-terminal lipid-binding domain of apoA-I drastically reduced the FC and PL efflux ( approximately 90%), indicating that the C-terminal amphipathic alpha-helix is required for high affinity microsolubilization of FC and PL. Deletion in the N-terminal region of apoA-I also reduced the lipid efflux ( approximately 30%) and increased the K(m) about 2-fold compared with wild type apoA-I, whereas deletion of the central domain (Delta123-166) had no effect on either K(m) or V(max). These results indicate that ABCA1-mediated lipid efflux is relatively insensitive to the organization of the apoA-I N-terminal helix-bundle domain. Alterations in apoA-I structure caused parallel changes in its ability to bind to a PL bilayer and to induce efflux of FC and PL. Overall, these results are consistent with a two-step model for ABCA1-mediated lipid efflux. In the first step, apoA-I binds to ABCA1 and hydrophobic alpha-helices in the C-terminal domain of apoA-I insert into the region of the perturbed PL bilayer created by the PL transport activity of ABCA1, thereby allowing the second step of lipidation of apoA-I and formation of nascent high density lipoprotein particles to occur.
Korjian S, Kazmi S, Chi G, Kalayci A, Lee J, Talib U Eur Heart J Cardiovasc Pharmacother. 2023; 9(4):387-398.
PMID: 36787889 PMC: 10236524. DOI: 10.1093/ehjcvp/pvad014.
Oxidative modification of HDL by lipid aldehydes impacts HDL function.
Fadaei R, Davies S Arch Biochem Biophys. 2022; 730:109397.
PMID: 36116503 PMC: 9670862. DOI: 10.1016/j.abb.2022.109397.
Sato Y, Kuwahara K, Mogami K, Takahashi K, Nishizawa S RSC Adv. 2022; 10(63):38323-38327.
PMID: 35517518 PMC: 9057301. DOI: 10.1039/d0ra07763a.
Bedi S, Morris J, Shah A, Hart R, Jerome W, Aller S J Lipid Res. 2022; 63(3):100168.
PMID: 35051413 PMC: 8953623. DOI: 10.1016/j.jlr.2022.100168.
Wang X, Wang D, Xia P, Cheng K, Wang Q, Wang X Bone Joint Res. 2021; 10(10):693-703.
PMID: 34666502 PMC: 8559971. DOI: 10.1302/2046-3758.1010.BJR-2021-0162.R3.